Molecular and Phenotypic Changes in FLExDUX4 Mice

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the aberrant expression of the double homeobox 4 (<i>DUX4</i>) gene. The <i>FLExDUX4</i> mouse model carries an inverted human <i>DUX4</i> transgene which has leaky <i>DUX4</i> transgene expres...

Full description

Bibliographic Details
Main Authors: Kelly Murphy, Aiping Zhang, Adam J. Bittel, Yi-Wen Chen
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/13/7/1040
_version_ 1797588703208538112
author Kelly Murphy
Aiping Zhang
Adam J. Bittel
Yi-Wen Chen
author_facet Kelly Murphy
Aiping Zhang
Adam J. Bittel
Yi-Wen Chen
author_sort Kelly Murphy
collection DOAJ
description Facioscapulohumeral muscular dystrophy (FSHD) is caused by the aberrant expression of the double homeobox 4 (<i>DUX4</i>) gene. The <i>FLExDUX4</i> mouse model carries an inverted human <i>DUX4</i> transgene which has leaky <i>DUX4</i> transgene expression at a very low level. No overt muscle pathology was reported before 16 weeks. The purpose of this study is to track and characterize the <i>FLExDUX4</i> phenotypes for a longer period, up to one year old. In addition, transcriptomic changes in the muscles of 2-month-old mice were investigated using RNA-seq. The results showed that male <i>FLExDUX4</i> mice developed more severe phenotypes and at a younger age in comparison to the female mice. These include lower body and muscle weight, and muscle weakness measured by grip strength measurements. Muscle pathological changes were observed at older ages, including fibrosis, decreased size of type IIa and IIx myofibers, and the development of aggregates containing TDP-43 in type IIb myofibers. Muscle transcriptomic data identified early molecular changes in biological pathways regulating circadian rhythm and adipogenesis. The study suggests a slow progressive change in molecular and muscle phenotypes in response to the low level of DUX4 expression in the <i>FLExDUX4</i> mice.
first_indexed 2024-03-11T00:55:46Z
format Article
id doaj.art-76a673f6f43340e4a0d8aa05366622fc
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-11T00:55:46Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-76a673f6f43340e4a0d8aa05366622fc2023-11-18T20:02:41ZengMDPI AGJournal of Personalized Medicine2075-44262023-06-01137104010.3390/jpm13071040Molecular and Phenotypic Changes in FLExDUX4 MiceKelly Murphy0Aiping Zhang1Adam J. Bittel2Yi-Wen Chen3Institute for Biomedical Sciences, The George Washington University, Washington, DC 20037, USACenter for Genetic Medicine Research, Children’s National Hospital, Washington, DC 20010, USACenter for Genetic Medicine Research, Children’s National Hospital, Washington, DC 20010, USAInstitute for Biomedical Sciences, The George Washington University, Washington, DC 20037, USAFacioscapulohumeral muscular dystrophy (FSHD) is caused by the aberrant expression of the double homeobox 4 (<i>DUX4</i>) gene. The <i>FLExDUX4</i> mouse model carries an inverted human <i>DUX4</i> transgene which has leaky <i>DUX4</i> transgene expression at a very low level. No overt muscle pathology was reported before 16 weeks. The purpose of this study is to track and characterize the <i>FLExDUX4</i> phenotypes for a longer period, up to one year old. In addition, transcriptomic changes in the muscles of 2-month-old mice were investigated using RNA-seq. The results showed that male <i>FLExDUX4</i> mice developed more severe phenotypes and at a younger age in comparison to the female mice. These include lower body and muscle weight, and muscle weakness measured by grip strength measurements. Muscle pathological changes were observed at older ages, including fibrosis, decreased size of type IIa and IIx myofibers, and the development of aggregates containing TDP-43 in type IIb myofibers. Muscle transcriptomic data identified early molecular changes in biological pathways regulating circadian rhythm and adipogenesis. The study suggests a slow progressive change in molecular and muscle phenotypes in response to the low level of DUX4 expression in the <i>FLExDUX4</i> mice.https://www.mdpi.com/2075-4426/13/7/1040facioscapulohumeralmusculardystrophyFSHD<i>FLExDUX4</i>DUX4
spellingShingle Kelly Murphy
Aiping Zhang
Adam J. Bittel
Yi-Wen Chen
Molecular and Phenotypic Changes in FLExDUX4 Mice
Journal of Personalized Medicine
facioscapulohumeral
muscular
dystrophy
FSHD
<i>FLExDUX4</i>
DUX4
title Molecular and Phenotypic Changes in FLExDUX4 Mice
title_full Molecular and Phenotypic Changes in FLExDUX4 Mice
title_fullStr Molecular and Phenotypic Changes in FLExDUX4 Mice
title_full_unstemmed Molecular and Phenotypic Changes in FLExDUX4 Mice
title_short Molecular and Phenotypic Changes in FLExDUX4 Mice
title_sort molecular and phenotypic changes in flexdux4 mice
topic facioscapulohumeral
muscular
dystrophy
FSHD
<i>FLExDUX4</i>
DUX4
url https://www.mdpi.com/2075-4426/13/7/1040
work_keys_str_mv AT kellymurphy molecularandphenotypicchangesinflexdux4mice
AT aipingzhang molecularandphenotypicchangesinflexdux4mice
AT adamjbittel molecularandphenotypicchangesinflexdux4mice
AT yiwenchen molecularandphenotypicchangesinflexdux4mice